Net Margin - Pharmaniaga Bhd (KLSE:PHARMA) - Alpha Spread
P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.395 MYR 1.28%
Market Cap: 569.3m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

Net Margin
Pharmaniaga Bhd

-1.6%
Current
-5%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1.6%
=
Net Income
-56.3m
/
Revenue
3.5B

Net Margin Across Competitors

Country MY
Market Cap 576.5m MYR
Net Margin
-2%
Country US
Market Cap 66.1B USD
Net Margin
1%
Country US
Market Cap 44.4B USD
Net Margin
1%
Country US
Market Cap 44.6B USD
Net Margin
1%
Country US
Market Cap 27B USD
Net Margin
0%
Country US
Market Cap 9.2B USD
Net Margin
3%
Country KR
Market Cap 12.2T KRW
Net Margin
7%
Country CN
Market Cap 54.3B CNY
Net Margin
2%
Country CN
Market Cap 53.4B HKD
Net Margin
1%
Country CN
Market Cap 48.3B CNY
Net Margin
8%
Country IT
Market Cap 6.1B EUR
Net Margin
7%

Profitability Report

View the profitability report to see the full profitability analysis for Pharmaniaga Bhd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1.6%
=
Net Income
-56.3m
/
Revenue
3.5B
What is the Net Margin of Pharmaniaga Bhd?

Based on Pharmaniaga Bhd's most recent financial statements, the company has Net Margin of -1.6%.